Weiss Multi-Strategy Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,000	Closed	-$457K	–	736
2017 Q4	$457K	Buy	+10,000	New	+$499K	0.01%	500
2015 Q2	–	Sell	-30,000	Closed	-$1.82M	–	580
2015 Q1	$1.82M	Sell	30,000 -10,000	-25%	-$485K	0.08%	254
2014 Q4	$2.09M	Buy	+40,000	New	+$1.79M	0.07%	210

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Weiss Multi-Strategy Advisers's JUNO Position: Q1 2018 in Review

Weiss Multi-Strategy Advisers sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 10,000 shares — an estimated $457K sold.

Weiss Multi-Strategy Advisers first reported a position in JUNO in Q4 2014 and held it in 3 quarters. The position peaked at $2.09M in Q4 2014. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Weiss Multi-Strategy Advisers reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $457K.
Weiss Multi-Strategy Advisers first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
Weiss Multi-Strategy Advisers's Juno Therapeutics, Inc. position peaked at $2.09M in Q4 2014.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.